PROS AND CONS OF OVERVIEWS OF RANDOMIZED TRIALS IN BREAST-CANCER AND VASCULAR-DISEASE

被引：0

|

作者：

PETO, R ^{[1
]}

机构：

[1] RADCLIFFE INFIRM,CLIN TRIAL SERV UNIT,OXFORD OX2 6HE,ENGLAND

来源：

ACTA PHARMACOLOGICA ET TOXICOLOGICA | 1986年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

下载

收藏

页码：149 / 149

页数：1

相关论文

共 50 条

[41] BREAST-CANCER TRIALS - A PATIENTS VIEWPOINT
THORNTON, HM
LANCET, 1992, 339 (8784): : 44 - 45
[42] TRIALS OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER
BLAMEY, RW
ELSTON, CW
LANCET, 1979, 1 (8122): : 920 - 920
[43] BREAST-CANCER TRIALS - A NEW INITIATIVE
PRICE, LA
BRITISH MEDICAL JOURNAL, 1980, 281 (6252): : 1422 - 1422
[44] TRIALS OF ADJUVANT THERAPY IN BREAST-CANCER
BAUM, M
LANCET, 1979, 1 (8124): : 1027 - 1027
[45] BREAST-CANCER TRIALS - A NEW INITIATIVE
HILL, BT
BRITISH MEDICAL JOURNAL, 1980, 281 (6254): : 1565 - 1565
[46] THE DISEASE-FREE INTERVAL IN BREAST-CANCER TRIALS - SCIENTIFIC OR SPURIOUS
MUELLER, CB
SURGERY, 1991, 110 (04) : 629 - 635
[47] LUNG-CANCER AND PERIPHERAL VASCULAR-DISEASE
SHEINER, NM
CANADIAN JOURNAL OF SURGERY, 1983, 26 (05) : 392 - 392
[48] BREAST-CANCER AND PRECEDING BREAST DISEASE
WEISS, NS
LANCET, 1976, 1 (7968): : 1076 - 1076
[49] Are We Ready to Abandon Placebo in Randomised Clinical Trials for Inflammatory Bowel Disease? Pros and Cons
Danese, Silvio
Schabel, Elmer
Masure, Johan
Plevy, Scott
Schreiber, Stefan
JOURNAL OF CROHNS & COLITIS, 2016, 10 : S548 - S552
[50] PROS AND CONS OF RANDOMIZED CONTROLLED TRIALS AND BENCHMARKING CONTROLLED TRIALS IN REHABILITATION: AN ACADEMIC DEBATE WITHIN THE EUROPEAN ACADEMY OF REHABILITATION MEDICINE
Malmivaara, A.
Zampolini, M.
Stam, H.
Gutenbrunner, C.
JOURNAL OF REHABILITATION MEDICINE, 2022, 54 : 1 - 8

← 1 2 3 4 5 →